Aquilo Capital Management, LLC
SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2021-08-16
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityAQUILO CAPITAL MANAGEMENT, LLC (US)
- Others nearbySan Francisco, CA
$384.9m
reported value
+5.0% vs Q1 2021
15positions
88.8%in top 10
0 new
10 added
2 reduced
0 sold out
vs Q1 2021
Holdings, Q2 2021
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| DICERNA PHARMACEUTICALS INC DRNA | $67.7m17.58% | Added +108.0k |
| SPERO THERAPEUTICS INC SPRO | $53.5m13.89% | Unchanged |
| BLUEPRINT MEDICINES CORP BPMC | $39.5m10.25% | Added +25.5k |
| ARROWHEAD PHARMACEUTICALS IN ARWR | $35.9m9.32% | Added +25.0k |
| UNIQURE NV QURE | $35.7m9.26% | Added +202.1k |
| MAGENTA THERAPEUTICS INC COM | $26.3m6.83% | Added +185.0k |
| NGM BIOPHARMACEUTICALS INC NGM | $23.6m6.12% | Added +70.0k |
| REGENXBIO INC RGNX | $23.1m6.01% | Added +36.0k |
| 4D MOLECULAR THERAPEUTICS IN FDMT | $22.8m5.92% | Added +644.5k |
| AMRYT PHARMA PLC SPONSORED ADS | $13.8m3.59% | Added +340.0k |
| PIERIS PHARMACEUTICALS INC COM | $12.2m3.18% | Reduced -479.0k |
| HARPOON THERAPEUTICS INC COM | $9.9m2.57% | Reduced -841.5k |
| GALAPAGOS NV LKFT | $9.8m2.55% | Added +25.6k |
| ARGENX SE ARGX | $6.4m1.66% | Unchanged |
| GENMAB A/S GMAB | $4.9m1.27% | Unchanged |